Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New ovine enzootic abortion vaccine in development
"We are very encouraged by the new vaccine results." - Dr David Longbottom.
The work is led by Dr David Longbottom, of the Moredun Research Institute. 

Scientists at the Moredun Research Institute are developing a new vaccine against ovine enzootic abortion.

Ovine enzootic abortion is the most common cause of abortion in sheep in the UK, and is caused by the bacteria Chlamydia abortus, which invades the placenta during pregnancy. The disease can also cause life-threatening illness and abortion in humans.

The disease spreads through ingestion and inhalation, and a high level of environmental contamination by infected ewes in lambing pens is a key point in the spread of disease.

Led by Dr David Longbottom, the scientists at Moredun have completed the first stage in the development of the vaccine, which is similar to the live variation, but does not possess the ability to grow and cause infections in the host animal. 

Dr Longbottom commented on the ongoing development process: “We are very encouraged that the new vaccine results in a similar protective response to that generated following a natural infection or resulting from the live vaccines but importantly without the ability to cause disease.”

More about the vaccine can be read in this study, published in Vaccines

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.